PROFFERED PAPERS
Monday, March 26   —  8:00 AM   —  CC 1 A/B


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



Section C - GYNECOLOGIC PATHOLOGY
Chaired by: Steven Silverberg and Edyta Pirog



TimeTitle and AuthorsItinerary
Planner
8:00 Endometrial Endometrioid Adenocarcinoma: A Pathological Analysis of 827 Consecutive Cases (906)
Z Ghorab, S Nofech-Mozes, N Ismiil, I Ackerman, G Thomas, A Covens, MA Khalifa University of Toronto, Toronto, ON, Canada
Add
8:15 Expression of PAX2 in Endometrial Hyperplasia and Carcinomas: Immunohistochemical Analysis of 136 Cases (869)
D Cao, AM Gown, RS Vang, RJ Kurman, BM Ronnett The Johns Hopkins Hospital, Baltimore, MD; Seattle, WA
Add
8:30 Impact of Microsatellite Instability (MSI) on Survival in High Grade Endometrial Carcinoma (858)
MH Arabi, M Cote, CS Bryant, JP Shah, AR Munkarah, R Ali-Fehmi Wayne State University, Detroit, MI
Add
8:45 FIGO Grade I Endometrioid Adenocarcinoma of the Uterine Corpus with Lymph Node Metastasis Closely Resembling Sinus Histiocytes: Reported Frequency in 79 Myoinvasive Cases (967)
CM Quick, JK McKenney University of Arkansas for Medical Sciences, Little Rock, AR
Add
9:00 Vascular “Pseudoinvasion” in Laparoscopic Hysterectomy Specimens: A Diagnostic Pitfall (913)
AV Herdman, KA Moller, S Logani Emory University, Atlanta, GA; Southwest Gynecologic Oncology Associates Inc, Albuquerque, NM
Add
9:15 Endometrial Serous Carcinoma Has a Strong Association with Breast Cancer, Particularly in Patients Younger Than 56 Years of Age (941)
S Liang, M Pearl, C Tornos, E Chalas, M Kelly, P Schwartz, T Zhang, W Zheng State University of New York, Stony Brook, NY; Yale University School of Medicine, New Haven, CT; Shangdon University, China; University of Arizona, Tucson, AZ
Add
9:30 RECESS, EXHIBITS, POSTER SESSION I  
11:00 Myxoid Leiomyosarcoma: A Clinicopathologic Study of Ten Cases (928)
D Kindelberger, M Hollowell, C Otis, M Nucci Brigham and Women's Hospital, Boston, MA; Baystate Medical Center, Springfield, MA
Add
11:15 Calponin h1 Expression Is an Independent Prognostic Factor in Uterine Leiomyosarcomas (978)
C Serrano, M Tebar, I Abdulkader, E Lerma, J Ordi, E Serrano, M Abad, E de Alava Centro de Investigación del Cáncer-Hospital Universitario de Salamanca, Salamanca, Spain; Leiden University Medical Center, Leiden, Netherlands; Santiago de Compostela, Spain; Hospital Sant Pau, Barcelona, Spain; Hospital Clínic, Barcelona, Spain
Add
11:30 Histopathologic Prognostic Factors in Stage I Uterine Leiomyosarcomas (Ut-LMS); a Clinicopathologic Study of 28 Cases (994)
WL Wang, RA Soslow, M Hensley, H Asad, GF Zannoni, M de Nictolis, P Branton, E Oliva Massachusetts General Hospital, Boston, MA; Memorial Sloan Kettering Cancer Center, New York, NY; Universita Cattolica, Rome, Italy; Istituto di Anatomia e Istologia Patologica, Ancona, Italy; Inova Fairfax Hospital, Church Falls, VA
Add
11:45 Mullerian Adenosarcoma: A Clinicopathologic and Immunohistochemical Study of 55 Cases (969)
A Ribe, F Saro, F Peiro, J Prat Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Barcelona, Spain; Hospital General de Elda, Elda, Valencia, Spain
Add